Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells.
about
Kaposi sarcoma herpes virus latency associated nuclear antigen protein release the G2/M cell cycle blocks by modulating ATM/ATR mediated checkpoint pathway3-D Microwell Array System for Culturing Virus Infected Tumor Cells.EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cellsKaposi's sarcoma-associated herpesvirus LANA recruits the DNA polymerase clamp loader to mediate efficient replication and virus persistenceLatent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypesResveratrol inhibits KSHV reactivation by lowering the levels of cellular EGR-1Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1Efficient lytic induction of Kaposi's sarcoma-associated herpesvirus (KSHV) by the anthracyclines.Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines.Molecular biology of KSHV lytic reactivation.The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells.Kaposi's sarcoma-associated herpesvirus ORF6 gene is essential in viral lytic replication.Infection of lymphoblastoid cell lines by Kaposi's sarcoma-associated herpesvirus: critical role of cell-associated virus.BH3 Profiling Reveals Selectivity by Herpesviruses for Specific Bcl-2 Proteins To Mediate Survival of Latently Infected Cells.Distinct domains in ORF52 tegument protein mediate essential functions in murine gammaherpesvirus 68 virion tegumentation and secondary envelopmentPersistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.Murine gammaherpesvirus 68 ORF52 encodes a tegument protein required for virion morphogenesis in the cytoplasm.Electrical response of a B lymphoma cell line latently infected with Kaposi's sarcoma herpesvirusMolecular approaches towards characterization, monitoring and targeting of viral-associated hematological malignancies.Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus.Establishment of B-cell lines latently infected with reactivation-competent murine gammaherpesvirus 68 provides evidence for viral alteration of a DNA damage-signaling cascade.Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cellsPhosphorylation of Kaposi's sarcoma-associated herpesvirus processivity factor ORF59 by a viral kinase modulates its ability to associate with RTA and oriLyt.Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells.Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.Lack of heparan sulfate expression in B-cell lines: implications for Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 infectionsHuman herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN.Expression and function of microRNAs encoded by Kaposi's sarcoma-associated herpesvirus.Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.Infection and persistence of rhesus monkey rhadinovirus in immortalized B-cell lines.KSHV and the Role of Notch Receptor Dysregulation in Disease Progression.Differential regulation of the attachment of Kaposi's sarcoma-associated herpesvirus (KSHV)-infected human B cells to extracellular matrix by KSHV-encoded gB and cellular alphaV integrinsReconstitution of immune responses against Kaposi sarcoma-associated herpesvirus.RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism.Metabolic reprogramming of Kaposi's sarcoma associated herpes virus infected B-cells in hypoxia.Micro RNAs from DNA Viruses are Found Widely in Plasma in a Large Observational Human Population.Experience with Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome in a Large Urban HIV Clinic in the United States: Case Series and Literature Review.The Kaposi's sarcoma-associated herpesvirus viral interleukin 6 gene affects metastasis and expression of B cell markers in a murine xenograft model
P2860
Q28540116-A20C3497-6775-4AA8-9435-7499D109A14DQ30367172-047219AB-A673-49B3-8463-300A7C81CE4AQ33261811-E1AD986F-898A-4BA6-8933-15CD1DAE8E99Q33934809-D0644E3E-75B4-4A2D-9BC6-9E51E188E6BEQ34060663-2CAD71AC-3F24-4A6B-8B2F-250634A81208Q34102739-34E0E9DD-0D15-4FE6-B073-7B1D3F841B7BQ34200840-B18424C1-FA76-4E4A-8688-142850DEC793Q34333665-F13367F4-8967-4327-9A34-CA2D6F7DE448Q34483652-8499E112-F247-4B5E-8D03-179DE2BD6C04Q34733560-C3332625-AF30-4EDB-833A-8C5070F9F17FQ35014918-FE08BEC0-205D-4CE3-A9F3-DE87AB27A6DAQ35071118-E061CA29-0D6C-4BA9-8B5A-D538C738B1E5Q35183996-BEA14003-F8E9-4910-A750-F02C27956E24Q35383336-7DF73666-CCAC-4D60-8A08-FDED0E8D5365Q35641404-08523644-952F-411C-8F42-7C07760ECAB8Q35689584-2B2A9D3C-C0A8-4163-BB57-E2695386B328Q35784707-2A81957D-DC7B-432C-9D23-3BCE90FE721BQ36098926-3D0391C4-F9FC-4259-89FD-DA5892520F38Q36654920-546F7378-7E9E-4F77-98D2-DDF4D35E8B6FQ36670930-58B307EE-4C55-46B5-B786-025BD2BA47D1Q36691938-1BF32209-7EAF-4B54-9E1D-2B254358A74EQ36804603-9D5CEB7E-D4B8-485B-9B1B-A83E91F32ACCQ36845797-DCF3B789-8382-47C1-BF2E-8AB0CBC3D321Q36978654-4AEADB67-3E93-4C08-86F2-E2E4A4E2038FQ38315444-283F61AD-5D17-43F5-9873-1B5F3588F6F3Q39852047-7B7D5B69-8720-4DB7-A35E-DC988D418309Q39931204-4DD11A8D-0283-413C-976A-FFB6388A93DDQ40002946-C143B1BA-D09F-4ED8-B927-D21E08DC59D3Q40155119-1F8C21E4-81F8-4067-B284-31AA21588C74Q40155828-6064B66C-C1D6-418D-A851-3E00FF228A78Q40304886-643409CD-EC8C-46E4-8A48-310853916265Q41662283-04E92D6C-E74A-4A13-A43A-1E9232FD6D97Q42008309-4D4FB5ED-304C-4D76-AB01-1FD6F5C058A6Q42446461-D8256026-2D66-4364-86AC-3132E262CD43Q47551073-EC989660-F736-4B37-AFAC-47B70DF6CD52Q53781024-1DEEDC32-EB1E-41FC-A6B3-F168398645DEQ54229820-70ECC64B-954F-48B1-B441-F1131497643EQ55395192-F1C5A47C-8651-4BAF-BDE5-2438D56E8130Q59126441-8033A2D8-A4F8-4461-BED5-59C4A60771E4
P2860
Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Establishment and maintenance ...... erpesvirus latency in B cells.
@ast
Establishment and maintenance ...... erpesvirus latency in B cells.
@en
Establishment and maintenance ...... erpesvirus latency in B cells.
@nl
type
label
Establishment and maintenance ...... erpesvirus latency in B cells.
@ast
Establishment and maintenance ...... erpesvirus latency in B cells.
@en
Establishment and maintenance ...... erpesvirus latency in B cells.
@nl
prefLabel
Establishment and maintenance ...... erpesvirus latency in B cells.
@ast
Establishment and maintenance ...... erpesvirus latency in B cells.
@en
Establishment and maintenance ...... erpesvirus latency in B cells.
@nl
P2860
P1433
P1476
Establishment and maintenance ...... erpesvirus latency in B cells.
@en
P2093
Michael Lagunoff
P2860
P304
14383-14391
P356
10.1128/JVI.79.22.14383-14391.2005
P407
P577
2005-11-01T00:00:00Z